edge page
EDGE  •  27-lug-2022

Psychedelics 

Counterpoint Global
Psychedelics have the potential to fundamentally reshape how we think about and treat not only mental illness but a host of other conditions as well. Counterpoint Global investigates how psychedelic therapy works, the potential wide-spread impact of this innovative treatment, and the roadblocks to medical adoption.

10241331_Psychedelics_Insight-Tile-1x1
 
edge page
EDGE  •  26-dic-2021

Drones 

Counterpoint Global
After decades of development in garages and hobby shops, small drones are finally ready to make an impact in the enterprise. We discuss the evolution of enterprise drones and how the technology could disrupt small package delivery and aerial data collection. We also discuss the regulatory and societal challenges facing the enterprise drone industry today and highlight recent progress towards overcoming those challenges.

10136491_Drones_Insight-Tile-2x2
 
edge page
EDGE  •  19-ott-2020

Quantum Computing 

Counterpoint Global
Quantum computers store and process information using the quantum mechanical properties of matter. Counterpoint Global investigates the impact this new hardware could have on processing speeds and its potential to tackle previously unsolvable computing problems.

9892603-Insight-Tile-1x1
 
edge page
EDGE  •  31-ago-2017

EDGE: Autonomous Vehicles 

Counterpoint Global
Counterpoint Global researches autonomous vehicles, which use a suite of sensors, actuators and a central computer to "perceive" the environment and automate the driving process. This technology could change our perception of personal transportation.

edge-autonomous-vehicle
 
edge page
EDGE  •  30-apr-2017

Machine Learning 

Counterpoint Global
Counterpoint Global examines machine learning, a new way to train computer systems to generate insights from data and apply those insights to new situations.

insight-8884181-2x1-tile
 
edge page
EDGE  •  31-gen-2017

Case Study: CRISPR 

Counterpoint Global
Counterpoint Global analyzes clustered regularly interspaced short palindromic repeats (CRISPR), a tool for genetic research that could birth new industries and disrupt existing medical treatments.

insight-8809028-tile
 
Warning Icon Siamo spiacenti, non sono disponibili versioni in italiano. Si prega di deselezionare la scelta solo italiano per visualizzare tutte le versioni.
Article Team Image
 
Counterpoint Global consists of 56 people, including 32 investors, four disruptive change researchers, two consilient researchers and two sustainability researchers. Counterpoint Global’s culture fosters collaboration, creativity, continued development, and differentiated thinking.
 
 

La presente comunicazione ha carattere promozionale.

Prima di procedere è necessario leggere attentamente tutti i Termini e le Condizioni che illustrano i vincoli legali e normativi che regolano la divulgazione delle informazioni relative ai prodotti di investimento Morgan Stanley Investment Management.

È possibile che i servizi illustrati in questo sito Web non siano disponibili in tutte le giurisdizioni o a qualsiasi persona. Per ulteriori informazioni, si rimanda alle condizioni d'uso.


Privacy e cookie    •    Istruzioni per l'uso

©  Morgan Stanley. Diritti riservati.